CORT Class Action Alert: Hagens Berman Alerts Corcept Therapeutics (NASDAQ: CORT) Investors to Securities Class Action and May 13, 2019 Lead Plaintiff Deadline

PRNewswire 19-Mar-2019 9:30 AM

SAN FRANCISCO, March 19, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Corcept Therapeutics Incorporated (NASDAQ:CORT) to the May 13, 2019 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the Northern District of California.  If you purchased or otherwise acquired Corcept Therapeutics securities between August 2, 2017 and February 5, 2019 and suffered losses contact Hagens Berman Sobol Shapiro LLP.  For more information click

https://www.hbsslaw.com/cases/CORT

or contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing

CORT@hbsslaw.com.

According to the complaint, during the class period Defendants misled investors by concealing (a) improper payments to doctors to promote its drug Korlym, (b) its aggressive promotion of Korlym for off-label uses, and (c) the possibility that the Company's sole specialty pharmacy was a related party.

In response to reports highlighting this- and other- potential misconduct, the price of Corcept shares has significantly fallen.

"We're focused on investors' losses and whether Defendants used a captured pharmacy to improperly boost sales or hide losses," said Hagens Berman partner Reed Kathrein.

Whistleblowers:  Persons with non-public information regarding Corcept should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email CORT@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 80+ attorneys in 10 offices across the country.  The Firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes can be found at www.hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

View original content to download multimedia:http://www.prnewswire.com/news-releases/cort-class-action-alert--hagens-berman-alerts-corcept-therapeutics-nasdaq-cort-investors-to-securities-class-action-and-may-13-2019-lead-plaintiff-deadline-300814611.html

SOURCE Hagens Berman Sobol Shapiro LLP